Monday, 23 June 2025 »  Login
in
Home
»
Hyderabad News
I am at

USFDA approves Dr Reddy's Drug

Dr. Reddy's Laboratories announces that the new drug, Azacitidine for Injection, has been approved by the USFDA.
Hyderabad | 17th September 2013
RELATED ARTICLES
Dr. Reddy's Laboratories announced today that Azacitidine for Injection 100 mg/vial, a bioequivalent generic version of the VIDAZA? (azacitidine for injection), has been approved by the United States Food & Drug Administration (USFDA), on September 16, 2013.

The launch of the product in the market is planned in the near-term. The VIDAZA? brand had US sales of approximately $378.5 million for the business year ending in July 2013, according to IMS Health.

Dr. Reddy's Azacitidine for Injection 100 mg/vial will be available in single use-vials. (INN)
filed in:  Healthcare, Pharma Industry, Dr. Reddy's Labs, Science & Technology
LATEST NEWS
Ready To Talk With AP On Banakacharla: Telangana CM Reinstate 5 Telangana Villages Merged Into AP: K Kavitha Nita Ambani Donates Rs 1 Crore To Balkampet Yellamma Temple Rythu Bharosa Deposited For Up To 7 Acres: Thummala
COMMENTS
Be the first to comment on USFDA approves Dr Reddy's Drug! Just use the simple form below.
LEAVE A COMMENT
fullhyd.com has 700,000+ monthly visits. Tell Hyderabad what you feel about USFDA approves Dr Reddy's Drug!
[no link to your name will appear, overriding global settings]
To preserve integrity, fullhyd.com allows ratings/comments only with a valid email. Your comments will be accepted once you give your email, and will be deleted if the email is not authenticated within 24 hours.
My name:

Dissatisfied with the results? Report a problem or error, or add a listing.
ADVERTISEMENT
SHOUTBOX!
{{todo.name}}
{{todo.date}}
[
]
{{ todo.summary }}... expand »
{{ todo.text }} « collapse
First  |  Prev  |   1   2  3  {{current_page-1}}  {{current_page}}  {{current_page+1}}  {{last_page-2}}  {{last_page-1}}  {{last_page}}   |  Next  |  Last
{{todos[0].name}}

{{todos[0].text}}

ADVERTISEMENT
This page was tagged for
azacitidine for injection+dr. reddy
hyderabad September 2013 News
Healthcare news
Pharma Industry updates
Follow fullhyd.com on
About Hyderabad
The Hyderabad Community
Improve fullhyd.com
More
Copyright © 2023 LRR Technologies (Hyderabad) Pvt Ltd. All rights reserved. fullhyd and fullhyderabad are registered trademarks of LRR Technologies (Hyderabad) Pvt Ltd. The textual, graphic, audio and audiovisual material in this site is protected by copyright law. You may not copy, distribute or use this material except as necessary for your personal, non-commercial use. Any trademarks are the properties of their respective owners.